» Articles » PMID: 35066871

AAPM Task Group Report 290: Respiratory Motion Management for Particle Therapy

Overview
Journal Med Phys
Specialty Biophysics
Date 2022 Jan 23
PMID 35066871
Authors
Affiliations
Soon will be listed here.
Abstract

Dose uncertainty induced by respiratory motion remains a major concern for treating thoracic and abdominal lesions using particle beams. This Task Group report reviews the impact of tumor motion and dosimetric considerations in particle radiotherapy, current motion-management techniques, and limitations for different particle-beam delivery modes (i.e., passive scattering, uniform scanning, and pencil-beam scanning). Furthermore, the report provides guidance and risk analysis for quality assurance of the motion-management procedures to ensure consistency and accuracy, and discusses future development and emerging motion-management strategies. This report supplements previously published AAPM report TG76, and considers aspects of motion management that are crucial to the accurate and safe delivery of particle-beam therapy. To that end, this report produces general recommendations for commissioning and facility-specific dosimetric characterization, motion assessment, treatment planning, active and passive motion-management techniques, image guidance and related decision-making, monitoring throughout therapy, and recommendations for vendors. Key among these recommendations are that: (1) facilities should perform thorough planning studies (using retrospective data) and develop standard operating procedures that address all aspects of therapy for any treatment site involving respiratory motion; (2) a risk-based methodology should be adopted for quality management and ongoing process improvement.

Citing Articles

Updates in Management of Unresectable Stage III Non Small Cell Lung Cancer: A Radiation Oncology Perspective.

Narra L, Kumar R, Deek M, Jabbour S Cancers (Basel). 2025; 16(24.

PMID: 39766132 PMC: 11674665. DOI: 10.3390/cancers16244233.


The first Korean carbon-ion radiation therapy facility: current status of the Heavy-ion Therapy Center at the Yonsei Cancer Center.

Han M, Choi S, Hong C, Kim Y, Koom W, Kim J Radiat Oncol J. 2025; 42(4):295-307.

PMID: 39748530 PMC: 11701461. DOI: 10.3857/roj.2024.00206.


Dosimetric Evaluation of Beam-specific PTV and Worst-case Optimization Methods for Liver Proton Therapy.

Yamano A, Inoue T, Shiba S, Shimo T, Yamanaka M, Shirata R In Vivo. 2024; 38(6):3059-3067.

PMID: 39477417 PMC: 11535939. DOI: 10.21873/invivo.13790.


Modeling of artificial intelligence-based respiratory motion prediction in MRI-guided radiotherapy: a review.

Zhang X, Yan D, Xiao H, Zhong R Radiat Oncol. 2024; 19(1):140.

PMID: 39380013 PMC: 11463122. DOI: 10.1186/s13014-024-02532-4.


Comparison of translation algorithms in determining maximum allowable CTV shifts for Real-Time Gated Proton Therapy (RGPT) robustness evaluation in prostate cancers.

Lee J, Lew K, Koh C, Lee J, Bettiol A, Park S J Appl Clin Med Phys. 2024; 26(1):e14543.

PMID: 39361510 PMC: 11713994. DOI: 10.1002/acm2.14543.


References
1.
Li H, Zhang X, Park P, Liu W, Chang J, Liao Z . Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients. Radiother Oncol. 2015; 114(3):367-72. PMC: 4400219. DOI: 10.1016/j.radonc.2015.01.017. View

2.
Patel S, Lu H, Nyamwanda J, Jimenez R, Taghian A, MacDonald S . Postmastectomy radiation therapy technique and cardiopulmonary sparing: A dosimetric comparative analysis between photons and protons with free breathing versus deep inspiration breath hold. Pract Radiat Oncol. 2017; 7(6):e377-e384. DOI: 10.1016/j.prro.2017.06.006. View

3.
Habermehl D, Debus J, Ganten T, Ganten M, Bauer J, Brecht I . Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response. Radiat Oncol. 2013; 8:59. PMC: 3663740. DOI: 10.1186/1748-717X-8-59. View

4.
Inoue T, Widder J, van Dijk L, Takegawa H, Koizumi M, Takashina M . Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016; 96(3):661-9. DOI: 10.1016/j.ijrobp.2016.06.2454. View

5.
Knutson N, Samson P, Hugo G, Goddu S, Reynoso F, Kavanaugh J . Radiation Therapy Workflow and Dosimetric Analysis from a Phase 1/2 Trial of Noninvasive Cardiac Radioablation for Ventricular Tachycardia. Int J Radiat Oncol Biol Phys. 2019; 104(5):1114-1123. DOI: 10.1016/j.ijrobp.2019.04.005. View